Slovenia's Krka fights for generic telmisartan and esomeprazole in European courts
This article was originally published in Scrip
Executive Summary
Slovenia's largest manufacturer of generic pharmaceuticals, Krka, is fighting in European courts to protect the right to sell its generic products – telmisartan in Poland and esomeprazole in Denmark, Germany and Norway.